Moderna
$190.01Change from previous close: +0.57%Absolute change: +$1.07
At a glance
- Revenue growth
- −39.93%
- 2025 vs 2024
- Net margin
- -145.2%
- 2024: -110.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 | 803 | 60.0 | 135 | 206 | 108 |
| Cost of revenue | 4,000 | 6,007 | 9,538 | 8,711 | 4,608 | 1,378 | 496 | 454 | 410 | 275 |
| Gross profit | -2,056 | -2,771 | -2,690 | 10,552 | 13,863 | -575 | -436 | -319 | -205 | -166 |
| Selling, general and administrative | 1,018 | 1,174 | 1,549 | 1,132 | 567 | 188 | 110 | 94.3 | 64.7 | 57.5 |
| Research and development | 3,132 | 4,543 | 4,845 | 3,295 | — | — | — | — | — | — |
| Operating income | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 | -763 | -546 | -413 | -269 | -224 |
| EBIT | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 | -763 | -546 | -413 | -269 | -224 |
| EBITDA | -2,859 | -3,756 | -3,618 | 9,768 | 13,528 | -732 | -515 | -388 | -249 | -209 |
| Interest expense | 10.0 | 24.0 | 38.0 | 29.0 | 17.0 | 10.0 | — | 3.1 | 0.1 | 0.1 |
| Pre-tax income | -2,768 | -3,607 | -3,942 | 9,575 | 13,285 | -744 | -515 | -384 | -256 | -215 |
| Income tax | 54.0 | -46.0 | 772 | 1,213 | 1,083 | 3.0 | -1.0 | 0.3 | -0.1 | 1.0 |
| Net income | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 | -747 | -514 | -385 | -256 | -216 |
| Net income to common shareholders | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 | -747 | -514 | -402 | -270 | -230 |
| Basic EPS | -7.25 | -9.27 | -12.34 | 21.22 | 30.28 | -1.96 | -1.55 | -4.95 | -4.18 | -3.79 |
| Diluted EPS | -7.25 | -9.27 | -12.34 | 20.12 | 28.29 | -1.96 | -1.55 | -4.95 | -4.18 | -3.79 |
| Average shares (basic) | 389 | 384 | 382 | 394 | 403 | 381 | 331 | 81.1 | 64.5 | 60.7 |
| Average shares (diluted) | 389 | 384 | 382 | 416 | 431 | 381 | 331 | 81.1 | 64.5 | 60.7 |